Hypertrophic cardiomyopathy (HCM) is an inherited form of heart disease that affects 1 in 500 individuals. Here it is shown that calcineurin, a calcium-regulated phosphatase, plays a critical role in the pathogenesis of HCM. Administration of the calcineurin inhibitors cyclosporin and FK506 prevented disease in mice that were genetically predisposed to develop HCM as a result of aberrant expression of tropomodulin, myosin light chain-2, or fetal β-tropomyosin in the heart. Cyclosporin had a similar effect in a rat model or pressure-overload hypertrophy. These results suggest that calcineurin inhibitors.
|Original language||English (US)|
|Number of pages||4|
|State||Published - Sep 11 1998|
ASJC Scopus subject areas